General Information of the Compound
| Compound ID |
CP0052015
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
6-Quinoxalinamine, N-(4,5-dihydro-1H-imidazol-2-yl)-
91147-43-2
AKOS030240596
BDBM50213029
Brimonidine impurity II
CHEMBL49395
CTK3I1267
DTXSID00436663
Imidazolidin-2-ylidene-quinoxalin-6-yl-amine
MolPort-039-240-453
N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-QUINOXALINAMINE
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
N-quinoxalin-6-ylimidazolidin-2-imine
SCHEMBL12860178
SCHEMBL679239
ZINC14042
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H11N5
|
||||||||||||||||||
| Molecular Weight |
213.244
|
||||||||||||||||||
| Canonical SMILES |
C1CN=C(Nc2ccc3nccnc3c2)N1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H11N5/c1-2-9-10(13-4-3-12-9)7-8(1)16-11-14-5-6-15-11/h1-4,7H,5-6H2,(H2,14,15,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PVKUNRLEOHFACD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound